Margaret A. Alexander - Sep 9, 2024 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Role
President and COO
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
OVID
Transactions as of
Sep 9, 2024
Transactions value $
$0
Form type
4
Date filed
9/11/2024, 05:38 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OVID Employee Stock Option (right to buy) Award $0 +140K $0.00 140K Sep 9, 2024 Common Stock 140K $1.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the Stock Option will vest and become exercisable on September 9, 2025 and the remaining shares will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued services through such date.